Coronavirus Disease 2019 (COVID-19) Vaccines Report: Contract Development and Manufacturing Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape" report has been added to ResearchAndMarkets.com's offering.

This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

• This report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry.

Reasons to Buy

• What are the pipeline COVID-19 prophylactic vaccines by developer type?
• What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?
• What is the distribution of COVID-19 prophylactic vaccines clinical trials?
• What and Where are CMOs vaccine manufacturing facilities?
• What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?
• What are the COVID-19 vaccine contract manufacturing service agreements by Service?
• What are the COVID-19 vaccine contract manufacturing service agreements by CMO?
• What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?

Key Topics Covered:

1 Executive Summary

2 Players

3 Technology Briefing

3.1 What is COVID-19?

3.2 COVID-19 Pipeline Vaccine Types and Technology

4 Trends

5 Industry Analysis

5.1 COVID-19 Pipeline Vaccines

5.2 COVID-19 Vaccine Projected Sales

5.3 Contract Manufacturing Capabilities for Vaccines

5.4 COVID-19 Vaccine Contract Service Agreements

5.5 Investors in COVID-19 Vaccine Manufacturing

5.5.1 Governments

5.5.2 Pharma Companies

5.5.3 CMOs

6 Value Chain

7 Companies

8 Appendix

Companies Mentioned (Partial List)

• 3T Biosciences Inc.
• 7 Hills Pharma LLC
• Abnova Corp.
• AbVision Inc.
• Acibadem University
• Adaptive Phage Therapeutics Inc.
• Adimmune Corp.
• Advanced BioScience Laboratories Inc.
• Advent Srl
• Aegis Life Inc.
• AGC Biologics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/je7mpw